Jul. 21 at 1:15 PM
$COCH
• Proprietary fully implanted cochlear implant technology with the potential to disrupt the hearing implant market.
• Massive untapped market opportunity with low current cochlear implant adoption worldwide.
• If clinical and regulatory milestones continue to be met, commercialization could significantly re-rate the company’s valuation.
• Strong intellectual property creates a potential long-term competitive moat.
Micro-cap valuation offers asymmetric upside if execution continues.
• Reduced dilution concerns following the termination of its ATM offering.
Insider buying reflects confidence from major shareholders.
• High-risk, high-reward opportunity with multi-bagger potential if the technology achieves commercial success.
http://tinyurl.com/4244x3ya
